pfizer glp 1 dips on new data for obesity drug acquired in $10B deal Robust Phase IIb for Pfizer's
Description
50 Online Pub :OL553-8

Rothman, S
SF: Writing original draft

All numerical data were double-checked against original publications

50 Online Pub :OL553-8

Rothman, S
SF: Writing original draft

All numerical data were double-checked against original publications

US$ 24.66
US$ 29.55
US$ 27.58
US$ 22.88
US$ 28.77
US$ 20.55